Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Myristica fragrans essential oil, commonly known as nutmeg essential oil, is a volatile oil obtained from the seeds or kernels of the *Myristica fragrans* tree. It contains a complex mixture of bioactive compounds, including sabinene, myristicin, alpha-pinene, beta-pinene, and terpinene-4-ol. The essential oil is widely investigated for its diverse pharmacological properties, including antimicrobial, anti-inflammatory, antioxidant, and analgesic activities. In clinical research, it has been evaluated as an alternative obturating material in pediatric pulpectomy (root canal filling of primary teeth) and as an active ingredient in mouthwash formulations for plaque and halitosis control. Additionally, it is being actively researched as a natural biopesticide and botanical insecticide to control *Aedes* mosquito populations and stored-product pests.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on myristica fragrans essential oil.